1. rudihorne
2. mozatoarts
1.mozatoarts 01/31/2018
Cascadian Therapeutics to be acquired by Seattle Genetics for $10.00/share in cash, or approximately $614 mln
2.rudihorne 01/02/2018
NEWS! Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW